Faron Pharmaceuticals Oy (FARN.L)
GBp 175.0
(2.94%)
GBp 175.0
(2.94%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -30.94 Million EUR | -3.03% |
| 2022 | -30.03 Million EUR | -41.71% |
| 2021 | -21.19 Million EUR | -25.07% |
| 2020 | -16.94 Million EUR | -27.78% |
| 2019 | -13.26 Million EUR | 33.97% |
| 2018 | -20.08 Million EUR | 4.62% |
| 2017 | -21.06 Million EUR | -126.6% |
| 2016 | -9.29 Million EUR | -50.19% |
| 2015 | -6.18 Million EUR | -353.67% |
| 2014 | -1.36 Million EUR | 9.55% |
| 2013 | -1.5 Million EUR | 38.7% |
| 2012 | -2.46 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -7197.50 EUR | 0.0% |
| 2024 Q1 | -7197.50 EUR | 16.38% |
| 2023 Q3 | -8607.00 EUR | -25.38% |
| 2023 Q4 | -8607.00 EUR | 0.0% |
| 2023 FY | -30.94 Million EUR | -3.03% |
| 2023 Q1 | -6865.00 EUR | 12.04% |
| 2023 Q2 | -6865.00 EUR | 0.0% |
| 2022 Q3 | -7804.50 EUR | -18.96% |
| 2022 Q4 | -7804.50 EUR | 0.0% |
| 2022 FY | -30.03 Million EUR | -41.71% |
| 2022 Q1 | -6560.50 EUR | -23.39% |
| 2022 Q2 | -6560.50 EUR | 0.0% |
| 2021 Q2 | -5280.00 EUR | 0.0% |
| 2021 Q4 | -5317.00 EUR | 0.0% |
| 2021 Q3 | -5317.00 EUR | -0.7% |
| 2021 FY | -21.19 Million EUR | -25.07% |
| 2021 Q1 | -5280.00 EUR | -9.99% |
| 2020 Q2 | -3671.50 EUR | 0.0% |
| 2020 Q1 | -3671.50 EUR | -7.2% |
| 2020 Q3 | -4800.50 EUR | -30.75% |
| 2020 FY | -16.94 Million EUR | -27.78% |
| 2020 Q4 | -4800.50 EUR | 0.0% |
| 2019 FY | -13.26 Million EUR | 33.97% |
| 2019 Q1 | -3206.00 EUR | -6.41% |
| 2019 Q2 | -3206.00 EUR | 0.0% |
| 2019 Q3 | -3425.00 EUR | -6.83% |
| 2019 Q4 | -3425.00 EUR | 0.0% |
| 2018 FY | -20.08 Million EUR | 4.62% |
| 2018 Q4 | -3013.00 EUR | 0.0% |
| 2018 Q3 | -3013.00 EUR | 57.14% |
| 2018 Q2 | -7030.00 EUR | 0.0% |
| 2018 Q1 | -7030.00 EUR | -1.07% |
| 2017 Q1 | -3575.00 EUR | -10.82% |
| 2017 Q2 | -3575.00 EUR | 0.0% |
| 2017 FY | -21.06 Million EUR | -126.6% |
| 2017 Q4 | -6955.50 EUR | 0.0% |
| 2017 Q3 | -6955.50 EUR | -94.56% |
| 2016 Q2 | -1843.00 EUR | 0.0% |
| 2016 Q4 | -3226.00 EUR | 0.0% |
| 2016 FY | -9.29 Million EUR | -50.19% |
| 2016 Q3 | -3226.00 EUR | -75.04% |
| 2016 Q1 | -1843.00 EUR | 1.86% |
| 2015 FY | -6.18 Million EUR | -353.67% |
| 2015 Q3 | -1878.00 EUR | -54.44% |
| 2015 Q4 | -1878.00 EUR | 0.0% |
| 2015 Q1 | -1216.00 EUR | -237.31% |
| 2015 Q2 | -1216.00 EUR | 0.0% |
| 2014 Q3 | -360.50 EUR | -12.13% |
| 2014 Q1 | -321.50 EUR | 0.0% |
| 2014 FY | -1.36 Million EUR | 9.55% |
| 2014 Q4 | -360.50 EUR | 0.0% |
| 2014 Q2 | -321.50 EUR | 0.0% |
| 2013 FY | -1.5 Million EUR | 38.7% |
| 2012 FY | -2.46 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|